HOTEL INFO: Please call us to assist with room reservation

Newport Marriott Hotel & Spa

www.marriott.com/en-us/hotels/pvdlw-newport-marriott-hotel-and-spa

Dr. Jennifer White, PharmD, William Carey University

Dr. Jennifer White received her PharmD from Creighton University. She completed a PGY1 residency at ProvidenceSt. Peter in Olympia, WA and then worked in acute care before re-locating to Biloxi, MS. She currently works as an Assistant Professor of Clinical Pharmacy at William Carey University. Jennifer splits her time between teaching and as a ambulatory care pharmacist at Keesler Air Force Base Medical Center. At her clinical site, her specialties include diabetes, hypertension, dyslipidemia, and hypothyroidism. Her teaching responsibilities include patient care management, self-care therapeutics, and oncology. Jennifer is an active member of APHA and faculty advisor for the students, as well as a member of AACP.

Friday October 15, 2027

NEW FDA MEDICATION APPROVALS

ACPE# TBA

Objectives:

1.  Differentiate between FDA drug development designations.

2.  List new drugs approved by the FDA from 2025-2027.

3.  Describe the approved indication, rolw in therapy, and common adverse effects for selected new drugs from 2025-2027.

Saturday October 16, 2027 

BEYOND THE SCALE: A PHARMACIST’S GUIDE TO MODERN OBESITY MANAGEMENT

ACPE# TBA

Objectives:

1.  Review the pathophysiology, risk factors, and obesity-related comorbidities associated with obesity.

2.  Apply evidence-based guidelines to develop individualized weight management plans, including nutrition, lifestyle, and physical activity recommendations.

3.  Evaluate pharmacologic treatment options for weight management based on efficacy, safety, patient-specific factors, and current guideline recommendations.

4.  Design and optimize medication therapy plans for patients with obesity and obesity-related comorbid conditions using patient case scenarios.

5.  Compare surgical treatment options for weight management, including indications, benefits, risks, and guideline recommendations for bariatric procedures and postoperative medication and nutrition management strategies.

Sunday October 17, 2027 

BRAIN HEALTH IN PRACTICE: WHAT PHARMACISTS NEED TO KNOW ABOUT ALZHEIMER’S and PARKINSON’S DISEASES

ACPE# TBA

Objectives:

1.  Review the pathophysiology, risk factors, clinical presentation, and disease progression of Alzheimer’s Disease and Parkinson’s Disease.

2.  Differentiate diagnostic criteria, stages of disease, and common motor, cognitive, and behavioral symptoms associated with Alzheimer’s Disease and Parkinson’s Disease.

3.  Apply current evidence-based treatment guidelines to optimize pharmacologic and non-pharmacologic management of Alzheimer’s Disease and Parkinson’s Disease.

4.  Evaluate the efficacy, safety, adverse effects, drug interactions, and monitoring parameters of medications used in the management of neurodegenerative disorders.

5.  Discuss emerging therapies, recent guideline updates, and advances in disease-modifying treatments for Alzheimer’s Disease and Parkinson’s Disease.

6.  Identify caregiver challenges, counseling strategies, and community resources that support patients and caregivers managing neurodegenerative diseases.